Profile: Otsuka America Pharmaceutical, Inc. (OAPI) is a fast-growing healthcare company that commercializes the Otsuka-group and other product opportunities in North America, with a strong focus on commitment to neuroscience, cardiovascular and gastrointestinal therapeutic treatments. Our products are marketed under the brand name Pletal® (cilostazol), Abilify®(aripiprazole) and Zegerid®(omeprazole) powder for oral suspension.